Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN

Name: Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN
License: Public Domain

Dana-Farber Cancer Institute

ClinicalTrials.gov · Datasets · License: Public Domain

squamous cell carcinoma of the head and neck

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 172292
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.